OCGN · Ocugen, Inc. · Proposed Sales
$0.81
-0.01 (-0.80%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 4, 2026
Substantial doubt about the company's ability to continue as a going concern.
“After evaluating these conditions and management’s plans, the Company has concluded that there is substantial doubt about the Company’s ability to continue as a going concern within one year after the date these unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Nov 4, 2026
Market Cap
$294.01M
Shares
339.31M
Volume · Nov 5
7.15M
Avg daily vol (3M)
6.56M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-07-09 | MARNA C. WHITTINGTON | Director | 112,205 | 2025-07-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-06-11 | PRABHAVATHI FERNANDES | Director | 146,705 | 2025-06-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-08-16 | RAMESH KUMAR | Director | 116,705 | 2024-08-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–3 of 3 filings
Key facts
CIK
1372299
CUSIP
67577C105
13F (30d)
57 filings
44 filers
Visit website
Investor relations